Home Medicine Analysis of ferritin genes in Parkinson disease
Article
Licensed
Unlicensed Requires Authentication

Analysis of ferritin genes in Parkinson disease

Published/Copyright: October 31, 2007
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 11

Abstract

Background: Genes that regulate iron metabolism may be involved in increasing brain iron content in Parkinson disease (PD). The ferritin L-chain is one of these genes, but the rare insertional mutations that cause neuroferritinopathy with basal ganglia degeneration have not yet been identified in PD.

Methods: We used denaturing HPLC (DHPLC) to investigate 124 PD patients and 180 controls for variations in the coding and in the 5′ untranslated regions of the H- and L-ferritin genes.

Results: In the H-ferritin gene, we found one new and rather common intronic polymorphism and the K54R substitution in two controls. The L-ferritin gene showed a very common L55L polymorphism and four other types of DNA variations, three of which were in the patient cohort. A mutation of the conserved His133 to Pro was found in a PD patient and in his daughter. The patient did not show signs of neuroferritinopathy, but the mutation was associated with low L-ferritin levels and with mild chronic anemia.

Conclusions: The results support the hypothesis that DNA variations in the ferritin genes are not a common cause for PD.

Clin Chem Lab Med 2007;45:1450–6.


Corresponding author: Prof. Paolo Arosio, PhD, Dipartimento Materno Infantile e Tecnologie Biomediche, Università di Brescia, Viale Europa 11, 25123 Brescia, Italy Phone: +39-030-394-386, Fax: +39-030-307-251,

Received: 2007-5-17
Accepted: 2007-6-30
Published Online: 2007-10-31
Published in Print: 2007-11-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Current state and future directions of neurochemical biomarkers for Alzheimer's disease
  2. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations
  3. Analysis of ferritin genes in Parkinson disease
  4. Multimers and adiponectin gene 276G>T polymorphism in the Japanese population residing in rural areas
  5. Evaluation of genus-specific and species-specific real-time PCR assays for the identification of Brucella spp.
  6. A polymorphism in the resistin gene promoter is related to increased C-reactive protein levels in patients with coronary artery disease
  7. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients
  8. How useful are housekeeping genes? Variable expression in melanoma metastases
  9. Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy
  10. Isobutyryl-CoA dehydrogenase deficiency with a novel ACAD8 gene mutation detected by tandem mass spectrometry newborn screening
  11. Circulating levels of osteoprotegerin and receptor activator of NF-κB ligand in patients with chronic renal failure
  12. Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factor
  13. Impact of rosiglitazone on the expression of β3-AR in the stable cell lines expressed β3-AR gene
  14. Biochemical and hormonal composition, cytological examination of thyroid cyst fluid, and comparison according to gender and color of cyst fluid
  15. Redefining functional sensitivity of thyroglobulin assay on Immulite platform: implications in thyroid cancer management
  16. Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age
  17. Umbilical cord blood serum procalcitonin by Time-Resolved Amplified Cryptate Emission (TRACE) technology: reference values of a potential marker of vertically transmitted neonatal sepsis
  18. Point-of-care creatinine testing in children at risk for sudden deterioration of renal function
  19. Utility of PFA-100® closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro
  20. Reliability assessment of glucose measurement by HemoCue analyser in a neonatal intensive care unit
  21. Validation study of Axis-Shield carbohydrate-deficient transferrin (CDT) on ARCHITECT® chemistry analyzer
  22. High free serum acrolein levels in bacterial infection and other disease states associated with oxidative stress: a potential biomarker?
  23. Increased serum S100B protein in chronic schizophrenic patients in Korea
  24. Addendum to the recent report of EC4 on the accreditation of medical laboratories in the European Union
  25. Reply to the letter written by Haeckel
  26. The systemic inflammatory response syndrome C-reactive protein and transthyretin conundrum
  27. Transthyretin, nutrition, and inflammation: response to Dr. Bernstein
  28. Erratum
Downloaded on 30.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.307/pdf
Scroll to top button